GetTopicDetailResponse(id=28e2144927e, topicName=Ponesimod, introduction=Ponesimod, content=null, image=null, comments=2, allHits=940, url=https://h5.medsci.cn/topic?id=14492, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=92584, tagList=[TagDto(tagId=92584, tagName=Ponesimod)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1621270, encodeId=5e0616212e03c, content=<a href='/topic/show?id=28e2144927e' target=_blank style='color:#2F92EE;'>#Ponesimod#</a>, objectTitle=Ponesimod治療成人多發(fā)性硬化癥：強(qiáng)生已向美國(guó)FDA提交新藥申請(qǐng)（NDA）, objectType=article, longId=190437, objectId=1dee19043e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dee19043e93, replyNumber=0, likeNumber=77, createdTime=2020-03-21, rootId=0, userName=李研東, userId=9c5820239546, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dee19043e93, moduleTitle=Ponesimod治療成人多發(fā)性硬化癥：強(qiáng)生已向美國(guó)FDA提交新藥申請(qǐng)（NDA）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1dee19043e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621269, encodeId=1c45162126973, content=<a href='/topic/show?id=28e2144927e' target=_blank style='color:#2F92EE;'>#Ponesimod#</a>, objectTitle=Ponesimod治療復(fù)發(fā)性多發(fā)性硬化癥的III期研究結(jié)果：符合其主要和次要終點(diǎn), objectType=article, longId=176219, objectId=d8491e621960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8491e621960, replyNumber=0, likeNumber=84, createdTime=2019-07-28, rootId=0, userName=李研東, userId=9c5820239546, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8491e621960, moduleTitle=Ponesimod治療復(fù)發(fā)性多發(fā)性硬化癥的III期研究結(jié)果：符合其主要和次要終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d8491e621960)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
